Gene expression profiling for the identification of G-protein coupled receptors in human platelets

被引:101
作者
Amisten, Stefan [1 ]
Braun, Oscar Oe [1 ]
Bengtsson, Anders [2 ]
Erlinge, David [1 ]
机构
[1] Univ Lund Hosp, Dept Cardiol, SE-22185 Lund, Sweden
[2] Univ Lund Hosp, Dept Rheumatol, SE-22185 Lund, Sweden
关键词
platelets; mRNA; P2; receptors; microarray; adenosine; GPCR;
D O I
10.1016/j.thromres.2007.08.014
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Introduction and materials and methods: G-protein coupled receptors (GPCRs) play an important role in platelet aggregation. To identify new platelet GPCRs, a platelet gene expression profile was generated and validated using quantitative real-time PCR. Results: In total, mRNA of 28 GPCR genes was detected in human platelets. The 12 most abundant platelet GPCR transcripts were: thrombin receptor PAR1 (1865 +/- 178%), ADIP receptor P2Y(12) (459 +/- 88%), succinate receptor 1 (257 +/- 48%), ADP receptor P2Y(1) (100%), orphan P2RY(10) (68.2 +/- 3.3%), lysophosphatidic acid receptors GPR23 (48.2 +/- 11%) and GPR92 (26.1 +/- 3.3%), adrenergic receptor alpha(2A) (18.4 +/- 4.4%), orphan EB12 (6.31 +/- 0.42), adenosine receptors A(2A) (2.94 +/- 0.24%) and A(2B) (2.88 +/- 0.16%) and lysophosphatidic acid receptor LPA(1) (2.59 +/- 0.39%) (% relative to the chosen calibrator P2Y(1)). The adenosine receptor A(2B) gene expression was validated with protein expression and functional studies. Western blot confirmed A2B receptor protein expression and platelet flow cytometry demonstrated inhibition of the effect of NECA by the adenosine A(2B)-antagonist MRS1754. Conclusions: We have detected several GPCRs not previously known to be expressed in platelets, including a functional adenosine A(2B) receptor. The findings could improve our understanding of platelet aggregation and provide new targets for drug development. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:47 / 57
页数:11
相关论文
共 44 条
[1]
Effects of oxytocin and prostaglandin F2α (enzaprost) on platelet aggregation [J].
Ailamazyan, EK ;
Petrishchev, NN ;
Vivulanets, EV ;
Maryutina, LV ;
Mindukshev, IV ;
Khachaturyan, AR .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 134 (05) :439-441
[2]
PLATELET THROMBUS FORMATION ON COLLAGEN TYPE-I - A MODEL OF DEEP VESSEL INJURY - INFLUENCE OF BLOOD RHEOLOGY, VONWILLEBRAND-FACTOR, AND BLOOD-COAGULATION [J].
BADIMON, L ;
BADIMON, JJ ;
TURITTO, VT ;
VALLABHAJOSULA, S ;
FUSTER, V .
CIRCULATION, 1988, 78 (06) :1431-1442
[3]
Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581
[4]
Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y1 and the P2Y12 receptor and is correlated with protein expression of P2Y12 [J].
Braun, Oscar Oe ;
Amisten, Stefan ;
Wihlborg, Anna-Karin ;
Hunting, Karen ;
Nilsson, David ;
Erlinge, David .
PURINERGIC SIGNALLING, 2007, 3 (03) :195-201
[5]
Bugert P, 2003, THROMB HAEMOSTASIS, V90, P738
[6]
INHIBITION OF PLATELET-AGGREGATION BY ADENOSINE RECEPTOR AGONISTS [J].
CRISTALLI, G ;
VITTORI, S ;
THOMPSON, RD ;
PADGETT, WL ;
SHI, D ;
DALY, JW ;
OLSSON, RA .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1994, 349 (06) :644-650
[7]
2-ALKYNYL DERIVATIVES OF ADENOSINE-5'-N-ETHYLURONAMIDE - SELECTIVE A(2) ADENOSINE RECEPTOR AGONISTS WITH POTENT INHIBITORY ACTIVITY ON PLATELET-AGGREGATION [J].
CRISTALLI, G ;
VOLPINI, R ;
VITTORI, S ;
CAMAIONI, E ;
MONOPOLI, A ;
CONTI, A ;
DIONISOTTI, S ;
ZOCCHI, C ;
ONGINI, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (11) :1720-1726
[8]
5'-N-ETHYLCARBOXAMIDOADENOSINE - A POTENT INHIBITOR OF HUMAN-PLATELET AGGREGATION [J].
CUSACK, NJ ;
HOURANI, SMO .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 72 (03) :443-447
[9]
Role of protease-activated and ADP receptor subtypes in thrombin generation on human platelets [J].
Dorsam, RT ;
Tuluc, M ;
Kunapuli, SP .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (05) :804-812
[10]
Central role of the P2Y12 receptor in platelet activation [J].
Dorsam, RT ;
Kunapuli, SP .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (03) :340-345